Navigation Links
Hanmi and Kinex Announced Korean FDA Allowance of the KX01 IND Application
Date:11/6/2012

BUFFALO, N.Y. and SEOUL, South Korea, Nov. 6, 2012 /PRNewswire/ -- Kinex Pharmaceuticals and Hanmi Pharmaceutical announced today that the Korean FDA (KFDA) has accepted Hanmi's Investigational New Drug (IND) application for KX-01, Kinex's dual src/pretubulin inhibitor, in the oncologic setting. The data package included Kinex's preclinical and clinical data for KX-01, as well as Hanmi's preclinical gastric cancer data.

KX01 differentiates itself as an inhibitor that targets the kinase substrate pocket and therefore offers an excellent efficacy as well as safety profile. In addition, KX01 has potent inhibitory activity against pre-tubulin. KX01 has been shown to be very effective against a broad range of cancers in both in vitro experiments and in animal cancer models. Importantly, the compound has synergistic/additive activities with a number of first line chemotherapeutic agents. A completed Phase I study, in patients with end-stage cancer, showed a desirable safety profile and stable disease or clinical response in approximately 25% of the patients. Proof-of-concept studies are ongoing. The composition of matter of KX01 is covered by issued patents.

Dr. Gwan-Sun Lee, President and CEO of Hanmi said, "This is another important milestone in our successful partnership with Kinex. This also demonstrates our growing focus and commitment to oncology therapeutics."

"This is a major step forward," added Dr. Jeewoong Son, Senior VP and Head of Innovation R&D, at Hanmi. "The close collaboration between our scientific teams has helped define our initial development strategy. Kinex is a great partner and continues to show strong support. We will continue focus our efforts on unmet oncology needs together."

"Kinex is pleased to be working with such a committed partner," commented Dr. Lyn Dyster, SVP of Operations. "Hanmi's ability to work with their local regulatory bodies to advance the KX01 development program in Korea is a cr
'/>"/>

SOURCE Kinex Pharmaceuticals
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Xiangxue Pharmaceuticals to Acquire Rights for a Promising Drug Candidate from Kinex Pharmaceuticals for the Greater China Territory
2. Kinex Pharmaceuticals Receives Substantial Strategic Investment
3. Kinex Pharmaceuticals Appoints Mr. Patrick Gallagher Vice President of Business Development and Investor Relations
4. Gen-Probe Withdraws from Previously Announced Investor Presentations
5. Genesis Biopharma Announces Termination of Previously Announced Proposed Public Offering
6. LTCLINK-Tank Competition Announced To Introduce Your Emerging Product to the Aging Care Continuum
7. Delcath Announced Changes To Board Of Directors
8. Speakers Announced for the 2012 International Iridoid Research Symposium
9. Bausch + Lomb Announces Extension of Early Tender Date for Its Previously Announced Tender Offer for Its 9 7/8% Senior Notes due 2015 (CUSIP Nos. 071707AN3, U07190AA6 and 071707AP8)
10. Online Pharmacy Domain Policy Changes Announced by ICANN Registrar Internet.bs Corp.
11. Bausch + Lomb Announces Final Results for Its Previously Announced Tender Offer for Its 9 7/8% Senior Notes due 2015 (CUSIP Nos. 071707AN3, U07190AA6 and 071707AP8)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... Capnia, Inc. (NASDAQ: CAPN ... based on its proprietary Sensalyze™ Technology Platform for ... results for the third quarter and nine months ... completion of our initial public offering (IPO), we ... initiated CoSense® commercial launch," said Anish Bhatnagar, M.D., ...
(Date:12/19/2014)... Dec. 18, 2014 Baptist Health Lexington is the ... to receive full Atrial Fibrillation with Electrophysiology Services (EPS) Accreditation ... Atrial fibrillation is the most common cardiac arrhythmia and ... cases can lead to stroke and possible death. More than ... have atrial fibrillation and the numbers are rapidly increasing ...
(Date:12/19/2014)... , Dec. 18, 2014   Aratana Therapeutics, ... biopharmaceutical company focused on the licensing, development and ... announced positive results from its pivotal field study ... treating pain in dogs with osteoarthritis.  In the ... assessment scores that were statistically significant compared to ...
Breaking Medicine Technology:Capnia Reports Third Quarter 2014 Financial Results 2Capnia Reports Third Quarter 2014 Financial Results 3Capnia Reports Third Quarter 2014 Financial Results 4Capnia Reports Third Quarter 2014 Financial Results 5Capnia Reports Third Quarter 2014 Financial Results 6Capnia Reports Third Quarter 2014 Financial Results 7Capnia Reports Third Quarter 2014 Financial Results 8Baptist Health Lexington First in the Nation to Receive Atrial Fibrillation with EPS Accreditation 2Baptist Health Lexington First in the Nation to Receive Atrial Fibrillation with EPS Accreditation 3Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 2Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 3Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 4Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 5
... , LEXINGTON, Mass. and HEIDELBERG, Germany, Dec. 2 ... of the "Top 10 Innovations of 2009" by The Scientist ... was selected due to its exceptional combinations of invention, vision and ... expert judges to evaluate a broad range of life science technologies ...
... ROYAL OAK, Mich., Dec. 2 ALERT ALARM, a ... the exclusive availability of new crystal necklace medical/security monitors. ... personal emergency response devices have a critical function; immediate ... ) , For elderly users, those with a medical ...
Cached Medicine Technology:The Scientist Magazine Recognizes febit's HybSelect(TM) Among the Winners of 'Top 10 Innovations of 2009' 2
(Date:12/19/2014)... 20, 2014 Today, Balfleet.com , ... outfits, announces its formal dress promotion. All the old ... to 60% off. , Balfleet.com is well-known for its ... dresses, prom dresses, cocktail dresses and more. Its formal ... money-back guarantee, and they can create an elegant look ...
(Date:12/19/2014)... Energy Textiles is excited to ... Celliant, the world’s leading responsive textile, can now ... There are a number of benefits to wearing ... and balanced body temperature; which can lead to ... enhanced athletic performance; and overall wellness. In addition, ...
(Date:12/19/2014)... December 19, 2014 Eufaula, Oklahoma, located ... Lake Eufaula, the state’s largest lake with more than ... is home to a little more than 3,000 residents, ... on Saturday, the 6th of December. , Featuring Santa, ... through downtown Eufaula on Main Street. Narconon Arrowhead’s ...
(Date:12/19/2014)... 2014 The print component of Vision ... subscription of the Toronto Star, with a circulation of ... The digital component is distributed nationally through a vast ... news sites and partner outlets. To explore the digital ... The publication features an exclusive interview with Mark ...
(Date:12/19/2014)... News) -- Potentially illness-causing E. coli bacteria were found ... according to a new study. Researchers checked cilantro, ... farmers markets in Los Angeles and Orange counties in ... 150 samples tested, 24 percent were positive for E. ... the researchers. Both types of bacteria can cause ...
Breaking Medicine News(10 mins):Health News:Balfleet.com Announces Its Formal Dress Promotion For 2015 2Health News:Energy Textiles Launches Celliant Revitalizing Bedsheets 2Health News:Narconon Arrowhead Debuts Float at Checotah and Eufaula Christmas Parades 2Health News:Narconon Arrowhead Debuts Float at Checotah and Eufaula Christmas Parades 3Health News:Mark DeMontis, Founder of Courage Canada, shares his passion for bringing hockey to those affected by blindness in Mediaplanet’s “Vision and Hearing” campaign 2Health News:E. Coli Germs Found on Farmers Market Herbs 2
... Goodwin HealthDay Reporter , TUESDAY, July 27 (HealthDay ... listener and speaker may look remarkably similar, especially when the ... Researchers asked 11 participants to listen to a recording ... asked to the senior prom when she was a high ...
... abused their children can stop if they are taught parenting ... found that mothers in families in which there is a ... how much they cursed at, yelled at, slapped, spanked, hit ... from therapists who taught them parenting skills. There were ...
... broken free from a tumor and is traveling through the ... a needle in a haystack. But a new imaging technique ... making this possible. UW researchers have developed a multifunctional nanoparticle ... of medical imaging essentially erasing the haystack, so the ...
... 2010 For decades research has shown that listening to music ... functioning, such as spatial awareness. However, until now, research has ... the cognitive benefit still the same if we listen to ... how does our preference for a particular type of music ...
... the Colorado Injury Control Research Center, the Center ... Hospital and the School of Public Heath, Tongji ... Technology, the USA-China Agricultural Injury Research Training Project ... provide training to Chinese scholars, expand collaborative research ...
... HealthDay Reporter , TUESDAY, July 27 (HealthDay News) -- ... Seeking out the right Web site might help, a new ... on to a specially designed Internet site for weight maintenance were ... than people who logged on less often, new research finds. ...
Cached Medicine News:Health News:In Conversation, People's Brains Can Mirror Each Other 2Health News:In Conversation, People's Brains Can Mirror Each Other 3Health News:Abusive mothers improve parenting after in-home training, emotional support of therapists 2Health News:Abusive mothers improve parenting after in-home training, emotional support of therapists 3Health News:Multifunctional nanoparticle enables new type of biological imaging 2Health News:Multifunctional nanoparticle enables new type of biological imaging 3Health News:Background music can impair performance, cites new study 2Health News:Trainee publication highlights success of US-China agricultural injury research training project 2Health News:To Help Keep Weight Off, Turn to the Web 2Health News:To Help Keep Weight Off, Turn to the Web 3
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a scientifically advanced nutritional formulation that ... full body health. MacularProtect Complete-S, based ... other advanced research, delivers a diverse ... mg of FloraGLO® lutein and other ...
... PreserVision® Soft Gel Lutein patented formula is ... Lomb PreserVision® AREDS formula, with the beta-carotene ... Lutein is a carotenoid found in dark ... is highly concentrated in the macula, the ...
Oculair (re-formulated Syntrx Complete) is a potent full-spectrum multiple vitamin/mineral/antioxidant dietary supplement that supports the normal aging process. It is designed to reflect the most re...
Medicine Products: